FDA Inspection 1194407 — Penn Fertility Care - Lancaster General Health
The FDA completed an inspection of Penn Fertility Care - Lancaster General Health on December 14, 2022 in Lancaster, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 14, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lancaster, PA (United States)